Davies B, Morris T. Physiological parameters in laboratory animals and humans.
Pharm Res 1993;10:1093–1095.
Dordal A, Lipkin M, Macritchie J, Mas J, Port A, Rose S, Salgado L, Savic V, Schmidt
W, Serafini MT, Spearing W, Torrens A, Yeste S. A preliminary study of the
metabolic stability of a series of benzoxazinone derivatives as potent neuropeptide
Y5 antagonists. Bioorg Med Chem Lett 2005;15:3679–3684.
Easterbrook J, Lu C, Sakai Y, Li AP. Effects of organic solvents on the activities of
cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol
sulfotransferase in human hepatocytes. Drug Metab Dispos 2001;29:141–144.
Fasco MJ, Piper LJ, Kaminsky LS. Biochemical applications of a quantitative high-
pressure liquid chromatographic assay of warfarin and its metabolites. J Chromatogr
1977;131:365–373.
Grant MH, Burke MD, Hawksworth GM, Duthie SJ, Engeset J, Petrie JC. Human
adult hepatocytes in primary monolayer culture. Maintenance of mixed function
oxidase and conjugation pathways of drug metabolism. Biochem Pharmacol 1987;
36:2311–2316.
Guengerich FP. Common and uncommon cytochrome P450 reactions related to
metabolism and chemical toxicity. Chem Res Toxicol 2001;14:611–650.
Hakala KS, Suchanova B, Luukkanen L, Ketola RA, Finel M, Kostiainen R. Rapid
simultaneous determination of metabolic clearance of multiple compounds catalyzed
in vitro by recombinant human UDP-glucuronosyltransferases. Anal Biochem
2005;341:105–112.
Hewawasam P, Erway M, Moon SL, Knipe J, Weiner H, Boissard CG, Post-Munson
DJ, Gao Q, Huang S, Gribkoff VK, Meanwell NA. Synthesis and structure–activity
relationships of 3-aryloxindoles: a new class of calcium-dependent, large conduc-
tance potassium (maxi-K) channel openers with neuroprotective properties. J Med
Chem 2002;45:1487–1499.
Hickman D, Wang JP, Wang Y, Unadkat JD. Evaluation of the selectivity ofin vitro
probes and suitability of organic solvents for the measurement of human cytochrome
P450 monooxygenase activities. Drug Metab Dispos 1998;3:207–215.
Holleran JL, Egorin MJ, Zuhowski EG, Parise RA, Musser SM, Pan SS. Use of high-
performance liquid chromatography to characterize the rapid decomposition of
wortmannin in tissue culture media. Anal Biochem 2003;323:19–25.
Houston JB, Galetin A. Progress towards prediction of human pharmacokinetic
parameters fromin vitrotechnologies. Drug Metab Rev 2003;35:393–415.
Ito K, Houston JB. Comparison of the use of liver models for predicting drug clearance
usingin vitrokinetic data from hepatic microsomes and isolated hepatocytes. Pharm
Res 2004;21:785–792.
Ito K, Houston JB. Prediction of human drug clearance fromin vitroand preclinical data
using physiologically based and empirical approaches. Pharm Res 2005;22:103–112.
Iwatsubo T, Hirota N, Ooie T, Suzuki H, Shimada N, Chiba K, Ishizaki T, Green CE,
Tyson CA, Sugiyama Y.Prediction ofin vivodrug metabolism in the human liver
fromin vitrometabolism data. Pharmacol Ther 1997;73:147–171.
Jenkins KM, Angeles R, Quintos MT, Xu R, Kassel DB, Rourick RA. Automated high
throughput ADME assays for metabolic stability and cytochrome P450 inhibition
profiling of combinatorial libraries. J Pharm Biomed Anal 2004;34:989–1004.
442 DETERMINATION OF METABOLIC RATES AND ENZYME KINETICS